Caxton Associates (New York)’s M.D.C. Holdings, Inc. MDC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
– Sell
-11,710
Closed -$252K – 668
2020
Q1
$252K Sell
11,710
-13,414
-53% -$470K 0.05% 298
2019
Q4
$888K Sell
25,124
-1,277
-5% -$48.1K 0.12% 100
2019
Q3
$1.05M Buy
+26,401
New +$927K 0.21% 37
2018
Q1
– Sell
-19,338
Closed -$529K – 467
2017
Q4
$529K Buy
+19,338
New +$533K 0.03% 289
2017
Q3
– Sell
-17,510
Closed -$491K – 650
2017
Q2
$491K Sell
17,510
-1,512
-8% -$39.6K 0.02% 347
2017
Q1
$454K Buy
+19,022
New +$429K ﹤0.01% 275

Other funds holding MDC

Caxton Associates (New York)'s MDC Position: Q2 2020 in Review

Caxton Associates (New York) sold out of M.D.C. Holdings, Inc. (MDC) in Q2 2020, closing a stake of 11,710 shares — an estimated $252K sold.

Caxton Associates (New York) first reported a position in MDC in Q1 2017 and held it in 6 quarters. The position peaked at $1.05M in Q3 2019. 244 funds tracked by Wall St. Rank hold MDC as of Q2 2020.

  • Caxton Associates (New York) reported no remaining M.D.C. Holdings, Inc. position as of Q2 2020 after selling out during the quarter.
  • Caxton Associates (New York) sold 11,710 M.D.C. Holdings, Inc. shares in Q2 2020, an estimated $252K.
  • Caxton Associates (New York) first reported a position in M.D.C. Holdings, Inc. in Q1 2017 and held it in 6 quarters.
  • Caxton Associates (New York)'s M.D.C. Holdings, Inc. position peaked at $1.05M in Q3 2019.
  • 244 funds tracked by Wall St. Rank held M.D.C. Holdings, Inc. as of Q2 2020.

Based on Caxton Associates (New York)'s 13F filing for Q2 2020, filed 14 Aug 2020.